![Carol Waldo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Carol Waldo worked as the Vice President of Regulatory Affairs at Cubist Pharmaceuticals LLC.
She then served as the Head of Regulatory Affairs at Spero Therapeutics, Inc. from 2016 to 2019.
Ms. Waldo's most recent position was as the Senior VP of Regulatory Affairs & Quality Assurance at Cidara Therapeutics, Inc. from 2021 to 2023.
She completed her undergraduate degree at North Central College.
Anciens postes connus de Carol Waldo
| Sociétés | Poste | Fin |
|---|---|---|
| CIDARA THERAPEUTICS | Corporate Officer/Principal | 01/08/2023 |
| SPERO THERAPEUTICS, INC. | Conseiller Juridique Général | 01/02/2019 |
| CUBIST PHARMACEUTICALS INC | Conseiller Juridique Général | - |
Formation de Carol Waldo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug-resistant bacterial infections | Health Technology |
North Central College
 North Central College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
